Treatment of obesity and essential hypertension and related...

Details Treatment of obesity and essential hypertension and related... Treatment of obesity and essential hypertension and related...

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 38/17 (2006.01) A61K 38/22 (2006.01) C07K 16/26 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2020786

191/165 ABSTRACT The administration of antagonists and blockers of amylin or CGRP or both for the treatment of obesity and essential hypertension and associated lipid disorders and atherosclerosis.

Affiliated with

Also associated with

Rating

Treatment of obesity and essential hypertension and related... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of obesity and essential hypertension and related..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of obesity and essential hypertension and related... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1787870